Provided by Tiger Trade Technology Pte. Ltd.

YieldMax HIMS Option Income Strategy ETF

12.25
+0.30042.51%
Post-market: 12.250.00000.00%19:59 EDT
Volume:46.01K
Turnover:558.05K
Market Cap:12.25M
PE:- -
High:12.31
Open:11.99
Low:11.94
Close:11.95
52wk High:53.97
52wk Low:9.53
Shares:1.00M
Float Shares:1.00M
Volume Ratio:0.79
T/O Rate:4.60%
Dividend:16.45
Dividend Rate:134.26%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap

THOMSON REUTERS
·
Jul 30

US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap

Reuters
·
Jul 30

Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says

THOMSON REUTERS
·
Jul 30

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

TIPRANKS
·
Jul 29

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

TIPRANKS
·
Jul 25

Hims & Hers falls -10.3%

TIPRANKS
·
Jul 25

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Dow Jones
·
Jul 23

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS
·
Jul 23

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Reuters
·
Jul 21

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Hims & Hers Accounting Chief Exits

Dow Jones
·
Jul 18